U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 148

Tests names and labsConditionsGenes, analytes, and microbesMethods

Invitae Congenital Ichthyosis Panel

Invitae
United States
7745
  • D Deletion/duplication analysis

Invitae Epidermolysis Bullosa and Palmoplantar Keratoderma Panel

Invitae
United States
9545
  • D Deletion/duplication analysis

Invitae Comprehensive Deafness Panel

Invitae
United States
405219
  • D Deletion/duplication analysis

GJB2 Regulatory Element Deletion Testing (GJB6-D13S1830 and GJB6-D13S1854)

PreventionGenetics, part of Exact Sciences
United States
71
  • T Targeted variant analysis

Deafness, digenic, GJB2/GJB3, 220290, Autosomal recessive, Digenic dominant (Autosomal recessive non-syndromic sensorineural deafness type DFNB) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Deafness, digenic, GJB2/GJB3, 220290, Autosomal recessive, Digenic dominant (Autosomal recessive non-syndromic sensorineural deafness type DFNB) (GJB3 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Deafness, digenic GJB2/GJB6, 220290, Autosomal recessive, Digenic dominant (Autosomal recessive non-syndromic sensorineural deafness type DFNB) (GJB6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Deafness, autosomal recessive 1A, 220290, Autosomal recessive, Digenic dominant (DFNB) (GJB2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Invitae Broad Carrier Screen without X-linked Disorders

Invitae
United States
19598
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Broad Carrier Screen

Invitae
United States
224112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Carrier Screen

Invitae
United States
886547
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GJB2-Related DFNB1 Nonsyndrome Hearing Loss and Deafness

Myriad Genetics, Inc.
United States
11
  • C Sequence analysis of the entire coding region

Hereditary Hearing Loss and Deafness Panel

PreventionGenetics, part of Exact Sciences
United States
360222
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GJB2/GJB6

Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics
United States
52
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MVL Vision Panel

Molecular Vision Laboratory
United States
342268
  • C Sequence analysis of the entire coding region

GJB6 (Connexin-30) copy number variation for hearing loss

Molecular Diagnostics Children's Hospital of Wisconsin
United States
21
  • D Deletion/duplication analysis

Hearing Loss Panel

Molecular Diagnostics Children's Hospital of Wisconsin
United States
95
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

qCarrier Plus

Quantitative Genomic Medicine Laboratories, SL
Spain
328300
  • C Sequence analysis of the entire coding region

Invitae Ectodermal Dysplasia and Related Disorders Panel

Invitae
United States
14873
  • D Deletion/duplication analysis

Deafness, Autosomal Dominant 2B (DFNA2B) via the GJB3 Gene

PreventionGenetics, part of Exact Sciences
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 21 to 40 of 148

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.